Looking back on a successful year of our “Molecule of the Month” series, we highlighted a wide range of innovative and high-quality molecules for research and clinical applications. Throughout the year, the series reflected our continuous evolution and strong focus on innovation. Find out the full Molecule of the Month 2025 highlights on our News section.
Thank you to everyone who followed, shared, and engaged with us – we look forward to another exciting year ahead.
ABX advanced biochemical compounds is a global frontrunner in radiopharmaceuticals, with a focus on positron emission tomography (PET) tracers. We develop and produce all compounds and components for any kind of radiotracer – from PET and SPECT precursors, PET reagent kits and cassettes, to complete radiopharmaceutical drug production in GMP environment.
Based in Radeberg, Germany, and founded in 1997, our team of about 400 employees is specialised in custom synthesis and manufacturing of precursors and peptides according to GMP for active pharmaceutical ingredients. Thanks to our expertise combined with bleeding edge equipment, we reach highest research, production, and quality standards.
ABX is the only service provider of radiopharmaceutical production with a complete and independent supply chain – from precursor or peptide to excipients and sterile disposables.
